in this issue
Markets :: Specialty Chemicals :: Water treatment
Ashland to sell water technologies, elastomers; earnings fall
July 25, 2013 | Vincent Valk
Ashland today reported fiscal third-quarter income from continuing operations down 26.9% year-on-year (YOY), to $117 million, on sales down 4%, to $2.1 billion. The declines were driven by a $17 million write-down of elastomers inventory due to sharply lower butadiene prices. Adjusted earnings, which include the elastomers write-down but exclude some environmental charges, totaled $1.66/share, well short of analysts’ consensus estimate of $1.84/share. Ashland’s fiscal third-quarter ended on 30 June. The company has also announced that intends to sell...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee